Urge HHS, FDA, DHS, and CBP to delay implementation of new prescription-medicine import procedures unless they provide assurances that genuine personal-use prescription medicines can continue entering the United States.

Chellie Pingree · Maine · Democratic

policy impact 0.62 specificity 0.86 extraction confidence 87%

Commitment kind: action. Promised action: Urge HHS, FDA, DHS, and CBP to delay implementation of new prescription-medicine import procedures absent clear assurances protecting personal-use prescription medicine imports.. Promised outcome: Genuine prescription medicines intended for personal use and not presenting unreasonable risk can continue entering the United States.. Deadline: unknown; not assumed expired. Signed congressional letter published October 2, 2026, concerning CBP international mail procedures scheduled to take effect October 22, 2026.

Contest this claim

Occurrences

“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines unless you can provide clear assurances that your agencies will not prevent genuine prescription medicines clearly intended for personal use and not appearing to present an unreasonable risk from entering the United States,” the members added.

Pingree joined members urging federal health and homeland-security agencies to delay new prescription-medicine import procedures unless access to genuine personal-use medicines is protected.

Schakowsky, Pocan Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congresswoman Jan Schakowsky
primary · press_release · model gpt-5.5

“Americans should not lose access to affordable medicines simply because the government has better information about packages entering the country. We urge your agencies to use that information to focus enforcement on where the risks are greatest while preserving appropriate access to safe and affordable medicines for personal use,” the members concluded.

Pingree joined members urging agencies to target enforcement toward high-risk shipments while preserving access to safe and affordable personal-use medicines.

Schakowsky, Pocan Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congresswoman Jan Schakowsky
primary · press_release · model gpt-5.5

Evidence

unverified · Source version 79717 · locator unknown

“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures”

Unverified model/legacy excerpt; not proof. AI summary (separate from source): House press release says a letter to HHS, DHS, FDA, and CBP urged delay unless agencies assure continued entry of genuine personal-use prescription medicines; it lists Chellie Pingree (ME-01) among the 71 signers.

delivered same_term A for effort

Schakowsky, Pocan Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congresswoman Jan Schakowsky
primary · model gpt-5.5 · confidence 94%

Contest this evidence item

unverified · Source version 79717 · locator unknown

"We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines unless you can provide clear assurances that your agencies will not prevent genuine prescription medicines clearly intended for personal use and not appearing to present an unreasonable risk from entering the United States,"

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official House release says the letter to HHS, FDA, DHS, and CBP made the requested delay-and-assurances ask; the signer list includes Chellie Pingree (ME-01).

delivered same_term A for effort

Schakowsky, Pocan Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congresswoman Jan Schakowsky
primary · model gpt-5.5 · confidence 96%

Contest this evidence item

Assessments

No assessments yet.